Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2010
08/31/2010US7786108 Compounds and method for treating dyslipidemia
08/31/2010US7786106 such as 3-[(4-methoxybenzoyl)-amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}phenyl beta -D-glucopyranoside, used as an activated blood coagulation factor X inhibitor; anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism
08/31/2010US7786105 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
08/31/2010US7786104 vanilloid receptor antagonists such as N-{6-[((R)-3-tert-Butoxycarbonylamino)pyrrolidin-1-yl]pyridin-3-yl}-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide, used as analgesics, antidepressants, antidiabetic agents, and for the treatment of gastrointestinal disorders or neurodegenerative diseases
08/31/2010US7786043 e.g.2-(5-chloro-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline; 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzonitrile
08/31/2010US7785904 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate
08/31/2010CA2574600C Pyridine derivatives
08/31/2010CA2569861C Pyrrolidine derivatives as ccr5 antagonists
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/31/2010CA2389545C Chemokine receptor binding heterocyclic compounds
08/26/2010WO2010096619A1 Process, purification and crystallization of 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
08/26/2010WO2010096371A2 Heterocyclic compounds which modulate the cb2 receptor
08/26/2010WO2010096314A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095144A2 Process for the preparation of proton pump inhibitors
08/26/2010WO2010094964A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
08/26/2010WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010WO2010094678A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010WO2010094667A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010WO2010094643A1 Quinoline derivatives and their uses for rhinitis and urticaria
08/26/2010WO2010094406A1 Aminopyrimidinamides as pest control agents
08/26/2010WO2010094405A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
08/26/2010WO2010045377A3 Pyrimidine non-classical cannabinoid compounds and related methods of use
08/26/2010WO2010009402A3 Nilotinib intermediates and preparation thereof
08/26/2010WO2009150547A3 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors
08/26/2010US20100216855 Imidazaolone derivatives,preparation thereof and biological use of same
08/26/2010US20100216846 Trisubstituted 1,2,4 triazoles
08/26/2010US20100216844 Carboxamide compounds and their use as calpain inhibitors
08/26/2010US20100216843 Novel salt 628
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216831 Desloratadine crystalline forms mixtures having a low level of residual solvents
08/26/2010US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products
08/26/2010US20100216815 N-substituted oxindoline derivatives as calcium channel blockers
08/26/2010US20100216814 Pyrido[4,3-b]indoles containing rigid moieties
08/26/2010US20100216813 Pyrrolidineanilines
08/26/2010US20100216809 Piperidine/piperazine derivatives
08/26/2010US20100216806 Ortho aminoamides for the treatment of cancer
08/26/2010US20100216794 Pyridine derivatives useful as glucokinase activators
08/26/2010US20100216793 Heteroaryl substituted pyridazinone derivatives
08/26/2010US20100216792 Pesticidal arylpyrrolidines
08/26/2010US20100216791 Pyridinylquinazolinamine derivatives and their use as b-raf inhibitors
08/26/2010US20100216786 New compounds
08/26/2010US20100216777 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
08/26/2010US20100216772 Novel Phenantridine Analogues and Uses Thereof
08/26/2010US20100216767 Quinazolines for pdk1 inhibition
08/26/2010US20100216764 Soluble Guanylate Cyclase Activators
08/26/2010US20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
08/26/2010US20100216758 Pyridone Compounds
08/26/2010US20100216750 Tricyclic inhibitors of fatty acid amide hydrolase
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof
08/26/2010US20100216252 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
08/26/2010US20100215742 Drug active in neuropathic pain
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100213832 Ambipolar host in organic light emitting diode
08/26/2010US20100213831 Ambipolar host in organic light emitting diode
08/26/2010US20100213829 Ambipolar host in organic light emitting diode
08/26/2010US20100213826 Material for organic photoelectric device, and organic photoelectric device thereby
08/26/2010US20100213453 Ambipolar host in organic light emitting diode
08/26/2010US20100212737 Dye including an anchoring group in its molecular structure
08/26/2010CA2752603A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010CA2752451A1 Aminopyrimidinamides as pest control agents
08/26/2010CA2752319A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
08/26/2010CA2751777A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010CA2750993A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010CA2749495A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010CA2748701A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221298A1 Phenylpyrazole derivatives
08/25/2010EP2220070A1 2-benzylpyridazinone derivatives as met kinase inhibitors
08/25/2010EP2220069A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220067A2 Process for preparing tetrahydroquinoline derivatives
08/25/2010EP2220055A2 Novel heterocyclyl compounds and their use as chemokine antagonists
08/25/2010EP2220054A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
08/25/2010EP2220053A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/25/2010EP2220052A1 Cyclic urea inhibitors of 11 -hydroxysteroid dehydrogenase 1
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220045A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
08/25/2010EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
08/25/2010EP2069302B1 Substituted pyridylmethyl bicyclocarboxyamide compounds
08/25/2010EP1994030B1 Multi-cyclic compounds and method of use
08/25/2010EP1966184B1 Pyridinyl-quinazoline derivatives and their medical use
08/25/2010EP1931641B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1778676B1 Hydantoin derivatives for the treatment of inflammatory disorders
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1080